Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten O Nielsen

Showing results (61-70 of 212) with videos related to

Pageof 22
Sort By:
Cancers|November 27, 2021
Prognostic Significance of CSF-1R Expression in Early Invasive Breast CancerNazia Riaz, Samantha Burugu, Angela S Cheng, et al.
Molecular Cytogenetics|July 6, 2010
Small blue round cell tumor of the interosseous membrane bearing a t(2;22)(q34;q12)/EWS-CREB1 translocation: a case reportMarina Pacheco, Douglas E Horsman, Malcolm M Hayes, et al.
Human Pathology|June 11, 2011
Low-grade fibromyxoid sarcoma of the perineum with heterotopic ossification: case report and review of the literatureAnna F Lee, Stephen Yip, Adam C Smith, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 25, 2025
Digital Profiling of Immune Biomarkers in Breast Cancer: Relation to Anthracycline BenefitElahe Shenasa, Ye He, Zehui Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
The MHCII Immune Activation Score predicts risk of recurrence and benefit of taxanes in Basal-like and HER2-enriched breast cancerPhilip S Bernard, Bingshu E Chen, Dongxia Gao, et al.
Human Pathology|April 17, 2009
Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarraysHongwei Cheng, Jim Dodge, Erika Mehl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical TrialTorsten O Nielsen, Maj-Brit Jensen, Samantha Burugu, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 17, 2007
Clinicopathologic factors and nuclear morphometry as independent prognosticators in KIT-positive gastrointestinal stromal tumorsSonja E Steigen, Bjørn Straume, Dmitry Turbin, et al.
Acta Oncologica (Stockholm, Sweden)|December 6, 2017
The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypesAnne-Vibeke Laenkholm, Maj-Britt Jensen, Jens Ole Eriksen, et al.
NPJ Breast Cancer|September 10, 2021
Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancerKarama Asleh, Nazia Riaz, Angela S Cheng, et al.
Pageof 22

Showing results (61-70 of 212) with videos related to

Sort By:
Pageof 22
Cancers|November 27, 2021
Prognostic Significance of CSF-1R Expression in Early Invasive Breast CancerNazia Riaz, Samantha Burugu, Angela S Cheng, et al.
Molecular Cytogenetics|July 6, 2010
Small blue round cell tumor of the interosseous membrane bearing a t(2;22)(q34;q12)/EWS-CREB1 translocation: a case reportMarina Pacheco, Douglas E Horsman, Malcolm M Hayes, et al.
Human Pathology|June 11, 2011
Low-grade fibromyxoid sarcoma of the perineum with heterotopic ossification: case report and review of the literatureAnna F Lee, Stephen Yip, Adam C Smith, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 25, 2025
Digital Profiling of Immune Biomarkers in Breast Cancer: Relation to Anthracycline BenefitElahe Shenasa, Ye He, Zehui Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
The MHCII Immune Activation Score predicts risk of recurrence and benefit of taxanes in Basal-like and HER2-enriched breast cancerPhilip S Bernard, Bingshu E Chen, Dongxia Gao, et al.
Human Pathology|April 17, 2009
Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarraysHongwei Cheng, Jim Dodge, Erika Mehl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical TrialTorsten O Nielsen, Maj-Brit Jensen, Samantha Burugu, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 17, 2007
Clinicopathologic factors and nuclear morphometry as independent prognosticators in KIT-positive gastrointestinal stromal tumorsSonja E Steigen, Bjørn Straume, Dmitry Turbin, et al.
Acta Oncologica (Stockholm, Sweden)|December 6, 2017
The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypesAnne-Vibeke Laenkholm, Maj-Britt Jensen, Jens Ole Eriksen, et al.
NPJ Breast Cancer|September 10, 2021
Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancerKarama Asleh, Nazia Riaz, Angela S Cheng, et al.
Pageof 22